
WhaleWisdom is probably the first result you got when you searched for a 13F tracker, and for good reason — it's been around a long time and has the deepest historical archive in the category. This post is a direct, two-way comparison against AlphaSMO, the site you're reading this on, written so you can decide whether WhaleWisdom's paid tiers are worth it for your specific use case, or whether a free alternative actually covers what you need.
| WhaleWisdom | AlphaSMO | |
|---|---|---|
| Filing history | Back to 2001 (paid tiers) | Rolling recent quarters |
| Free tier | 2-year lookback, 5-fund watchlist, basic alerts | Full site, no paywall |
| Cost | $90/quarter ($300/yr) Standard, $150/quarter ($500/yr) Pro | $0 |
| Funds trackable | 10 (Standard), 50 (Pro) | Unlimited browsing, watchlist included |
| Backtesting engine | Yes | No |
| Proprietary scoring | WhaleScore, WhaleIndex | Convergence confidence score |
| Insider (Form 4) data | No | Yes |
| 13F + insider overlap signal | No | Yes |
| Congressional STOCK Act trades | No | Yes |
| Public REST API | No | Yes, free |
| MCP server for AI agents | No | Yes |
(Pricing and feature details reflect what's publicly listed on WhaleWisdom's site as of this writing — check their current pricing page before deciding, since plans change.)
The honest starting point here: WhaleWisdom's paid archive going back to 2001 is a real, meaningful advantage if your work involves anything historical — comparing how a fund's positioning behaved across the 2008 crash, the 2020 crash, and multiple rate cycles isn't something a tool with only a couple years of data can support, full stop. Its backtesting engine is the other genuinely differentiated feature: you can simulate what following a specific fund's 13F-disclosed moves would have returned historically, which is a real (if imperfect — 13F data is inherently lagged and incomplete, since it only covers long U.S. equity positions) research tool. WhaleScore and WhaleIndex are proprietary ranking systems that have had over a decade to get tuned against real outcomes. And its free tier isn't nothing — 2 years of lookback, a 5-fund watchlist, and basic alerts is enough to seriously evaluate the product before paying.
If your actual use case is "I want to backtest a strategy against 20+ years of 13F history and I'm willing to pay for it," WhaleWisdom is doing something AlphaSMO doesn't do today, and we're not going to pretend otherwise.
We don't have WhaleWisdom's archive depth or its backtesting engine. What we built instead:
Institutional + insider overlap, automatically. A 13F tells you what a fund held at quarter-end. A Form 4 tells you what a company's own executives and directors bought or sold. WhaleWisdom (like most 13F-only trackers) doesn't cross-reference the two. AlphaSMO's smart-money convergence signal looks for tickers where both are happening in the same window and scores the overlap. Live numbers as of this writing: Simon Property Group (SPG) shows a convergence score of 79.06 with 11 distinct institutional buyers; KKR shows 80.48 with 5 buyers; Elevance Health (ELV) and W.R. Berkley (WRB) both show 70.0 with 2 buyers each; International Paper (IP) shows 62.59 with 3 buyers. That's not backtested — it's what the tracker shows right now, updating as new filings land.
A free public API and MCP server. WhaleWisdom doesn't offer a public API at any price tier. AlphaSMO's API covers 13F holdings, insider activity, stock flows, and the convergence signal itself, with no paywall — plus an MCP server so AI agents like Claude can query the data directly in a conversation. If you're building something on top of the data rather than just reading a dashboard, this is the practical reason to use AlphaSMO instead of, or alongside, WhaleWisdom.
Congressional trading data. Separate data type — trades disclosed by members of Congress under the STOCK Act — that WhaleWisdom doesn't track at all. Adjacent to the same "who's positioning early" question, just a different filing source.
Zero cost, no tier gate. WhaleWisdom's Standard tier alone runs $300/year if you pay annually, $360/year if you pay quarterly. AlphaSMO's equivalent functionality — browsing institutional holdings, insider activity, and the convergence signal — costs nothing, with no fund-count cap.
If you're a WhaleWisdom Standard subscriber for three years, that's roughly $900–1,080 depending on billing cadence. Pro is $1,500 over the same period. That's not a criticism — a mature, decade-plus-tuned product with a 20+ year archive and a backtesting engine is a reasonable thing to charge for. But it does mean the calculus is really about whether you specifically need that depth and that backtesting capability, versus whether recent-quarter institutional and insider data, for free, covers what you're actually trying to do.
It's worth being concrete about this rather than leaving it abstract. Backtesting a "follow this fund's 13F moves" strategy across 20+ years is genuinely useful if you're testing whether a specific manager's disclosed positioning has historically preceded outperformance — say, checking whether buying whatever Berkshire added last quarter, three months after the fact (13F filings are lagged by up to 45 days, so you're never seeing real-time positioning), would have beaten the S&P 500 over multiple cycles. That's a legitimate question, and WhaleWisdom's tooling is built for exactly it.
But a lot of the traffic searching for a "13F tracker" isn't trying to backtest a multi-decade strategy — it's someone who wants to know, this quarter, which institutions are accumulating a stock they already own or are considering, and whether that lines up with what the company's own insiders are doing with their own money. That's a fundamentally different, more current-events-oriented use case, and it's the one AlphaSMO is actually built around. Neither use case is more legitimate than the other — they're just different questions, and it's worth being honest with yourself about which one you're actually asking before picking a tool (or paying for one).
It's fair to be skeptical of "free" claims in fintech data tools — a lot of "free" products either monetize your data, bury the useful parts behind a paywall two clicks in, or are loss-leaders for something else you'll eventually be upsold on. To be transparent: AlphaSMO's read access is free because the underlying data — 13F, Form 4, Form 144, 8-K, congressional trading disclosures — is itself public SEC/government data, and the site's economics rely on the public API and site traffic rather than gating the core data behind a subscription. That's a different model from WhaleWisdom's, which has real licensing, infrastructure, and two decades of data-cleaning labor to fund, and charges accordingly. Neither model is wrong; they're just optimized for different things.
If you can answer yes to any of these, lean WhaleWisdom: you need pre-2015 institutional ownership data, you want to formally backtest a 13F-following strategy, or you specifically value a scoring system that's been tuned against outcomes for over a decade. If you can answer yes to any of these instead, lean AlphaSMO: you want to see institutional buying and insider buying converge on the same ticker in the same window, you want a free public API or MCP access rather than a paid one, you're curious about congressional trading alongside 13F data, or you simply don't want to pay anything to get started. If you answered yes to items on both lists, that's a real signal to use both — plenty of people do, and there's no licensing conflict in reading two different dashboards.
Can I get WhaleWisdom's 2001+ archive anywhere for free? Not that we're aware of, at least not at the depth and cleanliness WhaleWisdom offers. If deep historical backtesting is your core need, that's the one place their paid tier is hard to substitute.
Does AlphaSMO have a backtesting engine? Not today. If that's central to your workflow, WhaleWisdom is the better fit right now.
Is AlphaSMO actually free, or a freemium trap? Read access — holdings, insider activity, the convergence signal, and the public API — has no paywall or signup wall today. Nothing described in this post sits behind a paid tier.
Do people use both? Yes, reasonably often — WhaleWisdom for deep historical research and backtesting, AlphaSMO for the convergence signal, congress data, and anything built on the free API.
If you want to see the convergence signal for yourself, the smart money convergence page is free to browse, and the public API docs are open with no signup wall for read access.
An independent comparison of Fintel's paid multi-signal data platform and Dataroma's free curated superinvestor list — coverage, pricing, and who each is for.
An independent comparison of WhaleWisdom's paid 13F archive and Dataroma's free curated superinvestor list — when the free tool is enough, and when it isn't.
An independent comparison of WhaleWisdom and Fintel — historical depth vs data breadth, pricing tiers, backtesting, and which one fits which research workflow.